We measured the mRNA levels of apolipoprotein E receptor type 2 (ApoER2) and very low-density lipoprotein receptor (VLDLR) in peripheral blood lymphocytes from 43 patients with major depressive disorder (27 drug-free patients and 16 medicated patients) and 43 age-matched healthy controls using a quantitative real-time RT-PCR method. The correlations between mRNA levels of both receptors and clinical variables in patients were also examined. The expression of ApoER2 mRNA, but not VLDLR, was significantly lower in patients as compared to controls, irrespective of the medication status. There was no statistically significant correlation between the reduction of ApoER2 mRNA levels and any of the clinical variables measured in patients. Results from this preliminary study suggest that the expression of ApoER2 may serve as a trait marker for major depressive disorder.
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Introduction
Major depressive disorder (MDD) is one of the most common psychiatric disorders worldwide (Ebmeier et al., 2006; Ustün et al., 2004) . Evidence implicates the involvement of altered immune response and inflammation in the development of MDD (Irwin and Miller, 2007) . Patients with MDD have been reported to show signs of activated innate immune responses as manifested by increased inflammatory cytokines, including tumor necrosis factor-alpha, interleukin (IL)-1 and IL-6, in the peripheral blood and cerebrospinal fluid (Khairova et al., 2009; Kim et al., 2007; Müller and Ackenheil, 1998; Zorilla et al., 2001) . The potential role played by lymphocytes in the adaptive immune response has also been implicated in MDD (Miller, 2010) . For instance, T cell responses to mitogens have been shown to be decreased in depressed individuals (Kronfol et al., 1986; Schleifer et al., 1984) , and the skin response to commonly encountered antigens as a measure of T cell-mediated immune function is also decreased in patients with MDD (Hickie et al., 1993) . Furthermore, the number of B cells in patients with MDD is reported to be decreased as compared to the number in controls (Pavón et al., 2006; Schleifer et al., 1984) , although conflicting results have also been reported (Hernandez et al., 2010; Ravindran et al., 1998; Robertson et al., 2005) . A decrease in the responsiveness, or possibly the number, of peripheral blood lymphocytes in MDD patients is believed to be related to increased apoptosis (Eilat et al., 1999; Szuster-Ciesielska et al., 2008) , although the detailed mechanism of this relationship remains to be elucidated.
Apolipoprotein E (ApoE) is a multifunctional component of plasma lipoproteins (Nimpf and Schneider, 2000) . In addition to its functions in lipoprotein metabolism via the low-density lipoprotein (LDL) receptor family, apoE is known to act as an immunomodulator. ApoE is produced by macrophages (Basu et al., 1983; Kockx et al., 2008) , which activate T cells by antigen presentation (Mistry et al., 1995; van den Elzen et al., 2005) . ApoE has also been implicated in the activation of natural killer T cells by acting as a molecular chaperone for bacterial antigens, delivering them to antigen-presenting cells via LDL receptors (Allan et al., 2009 ). These findings indicate that apoE and its receptors on lymphocytes are implicated in the adaptive immune responses via intercellular signaling systems. With regard to the LDL receptor family that binds to apoE, apolipoprotein E receptor type 2 (ApoER2) and very low-density lipoprotein receptor (VLDLR) are implicated in the pathophysiology of MDD. These receptors bind to reelin, an extracellular matrix glycoprotein that plays crucial roles in brain development as well as in synaptic plasticity in the adult brain 
